Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 3 (2006), Issue 9 (September)

1. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome.
   Ophthalmology, 113(9): 1657-64. [Abstract] [Full-text]
2. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
   Lancet, 368(9538): 843-54. [Abstract] [Full-text]
3. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
   J Urol, 176(4): 1415-9. [Abstract] [Full-text]
4. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
   J Urol, 176(4): 1399-403. [Abstract] [Full-text]
5. Glomus jugulare tumors: the option of gamma knife radiosurgery.
   Neurosurgery, 59(3): 561-9; discussion 561-9. [Abstract] [Full-text]
6. Outcomes of surgery for resection of regions of symptomatic radiation injury after stereotactic radiosurgery for arteriovenous malformations.
   Neurosurgery, 59(3): 553-60; discussion 553-60. [Abstract] [Full-text]
7. Volume definition in radiotherapy planning for lung cancer: how the radiologist can help.
   Cancer Imaging, 6: 116-23. [Abstract] [Full-text]
8. Radiation shielding design of a new tomotherapy facility.
   Health Phys, 91(4): 289-95. [Abstract] [Full-text]
9. Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate.
   Int J Radiat Oncol Biol Phys, 66(2): 603-9. [Abstract] [Full-text]
10. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer.
    Int J Radiat Oncol Biol Phys, 66(2): 583-92. [Abstract] [Full-text]
11. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant.
    Int J Radiat Oncol Biol Phys, 66(2): 520-7. [Abstract] [Full-text]
12. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Int J Radiat Oncol Biol Phys, 66(2): 439-44. [Abstract] [Full-text]
13. Image-guided radiotherapy using megavoltage cone-beam computed tomography for treatment of paraspinous tumors in the presence of orthopedic hardware.
    Int J Radiat Oncol Biol Phys, 66(2): 323-6. [Abstract] [Full-text]
14. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis.
    Int J Radiat Oncol Biol Phys, 66(2): 620-5. [Abstract] [Full-text]
15. Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.
    Int J Radiat Oncol Biol Phys, 66(2): 424-9. [Abstract] [Full-text]
16. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys, 66(2): 408-15. [Abstract] [Full-text]
17. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study.
    Int J Radiat Oncol Biol Phys, 66(2): 416-23. [Abstract] [Full-text]
18. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy.
    Int J Radiat Oncol Biol Phys, 66(2): 454-61. [Abstract] [Full-text]
19. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 66(2): 445-53. [Abstract] [Full-text]
20. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
    Int J Radiat Oncol Biol Phys, 66(2): 339-44. [Abstract] [Full-text]
21. Accuracy and precision of an external-marker tracking-system for radiotherapy treatments.
    Br J Radiol, 79(946): 808-17. [Abstract] [Full-text]
22. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression.
    Int Immunopharmacol, 6(11): 1706-13. [Abstract] [Full-text]
23. Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma.
    J Clin Oncol, 24(27): 4418-25. [Abstract] [Full-text]
24. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
    Gynecol Oncol, 103(1): 94-9. [Abstract] [Full-text]
25. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Cancer, 107(6): 1287-93. [Abstract] [Full-text]
26. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Cancer, 107(6): 1321-30. [Abstract] [Full-text]
27. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study.
    Cancer, 107(6): 1355-64. [Abstract] [Full-text]
28. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.
    Cancer, 107(6): 1303-12. [Abstract] [Full-text]
29. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
    J Clin Oncol, 24(28): 4620-5. [Abstract] [Full-text]
30. Genomic prediction of locoregional recurrence after mastectomy in breast cancer.
    J Clin Oncol, 24(28): 4594-602. [Abstract] [Full-text]

© 2004-2010 Radiotherapy Research Today. All Rights Reserved.